Cargando…

Mechanisms Underlying Cell Therapy in Liver Fibrosis: An Overview

Fibrosis is a common feature in most pathogenetic processes in the liver, and usually results from a chronic insult that depletes the regenerative capacity of hepatocytes and activates multiple inflammatory pathways, recruiting resident and circulating immune cells, endothelial cells, non-parenchyma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pinheiro, Daphne, Dias, Isabelle, Ribeiro Silva, Karina, Stumbo, Ana Carolina, Thole, Alessandra, Cortez, Erika, de Carvalho, Lais, Weiskirchen, Ralf, Carvalho, Simone
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6912561/ https://www.ncbi.nlm.nih.gov/pubmed/31671842 http://dx.doi.org/10.3390/cells8111339

Ejemplares similares

Secretome effect of adipose tissue-derived stem cells cultured two-dimensionally and three-dimensionally in mice with streptozocin induced type 1 diabetes
por: Dias, Isabelle, et al.
Publicado: (2021)

Cytokines, hepatic cell profiling and cell interactions during bone marrow cell therapy for liver fibrosis in cholestatic mice
por: Pinheiro, Daphne, et al.
Publicado: (2017)

Bone marrow-derived mesenchymal stem cells transplantation ameliorates renal injury through anti-fibrotic and anti-inflammatory effects in chronic experimental renovascular disease
por: Almeida, Aline, et al.
Publicado: (2022)

Therapeutic potential of mesenchymal stem cells in multiple organs affected by COVID-19
por: Paris, Gustavo C., et al.
Publicado: (2021)

Cellular Mechanisms of Liver Fibrosis
por: Acharya, Pragyan, et al.
Publicado: (2021)

Lymphocytes Mitochondrial Physiology as Biomarker of Energy Metabolism during Fasted and Fed Conditions
por: Cortez, Erika, et al.
Publicado: (2012)

Special Issue on “Cellular and Molecular Mechanisms Underlying the Pathogenesis of Hepatic Fibrosis”
por: Weiskirchen, Ralf
Publicado: (2020)

Special Issue on “Cellular and Molecular Mechanisms Underlying the Pathogenesis of Hepatic Fibrosis II”
por: Weiskirchen, Ralf
Publicado: (2022)

Recent advances in understanding liver fibrosis: bridging basic science and individualized treatment concepts
por: Weiskirchen, Ralf, et al.
Publicado: (2018)

Magnetic-Assisted Treatment of Liver Fibrosis
por: Levada, Kateryna, et al.
Publicado: (2019)

Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH)-related liver fibrosis: mechanisms, treatment and prevention
por: Tacke, Frank, et al.
Publicado: (2021)

Editorial: Inflammation and Fibrosis in the Gastrointestinal Tract and Liver: Mechanisms and Targets
por: Weiskirchen, Ralf, et al.
Publicado: (2021)

Therapeutic Targeting of Hepatic Macrophages for the Treatment of Liver Diseases
por: van der Heide, Daphne, et al.
Publicado: (2019)

It’s all about the spaces between cells: role of extracellular matrix in liver fibrosis
por: Khurana, Amit, et al.
Publicado: (2021)

Endoglin in human liver disease and murine models of liver fibrosis—A protective factor against liver fibrosis
por: Alsamman, Muhammad, et al.
Publicado: (2017)

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis
por: Tag, Carmen G., et al.
Publicado: (2015)

Single Cell RNA Sequencing Identifies Subsets of Hepatic Stellate Cells and Myofibroblasts in Liver Fibrosis
por: Krenkel, Oliver, et al.
Publicado: (2019)

Development and evaluation of an open source Delphi-based software for morphometric quantification of liver fibrosis
por: Huss, Sebastian, et al.
Publicado: (2010)

Software solutions for evaluation and visualization of laser ablation inductively coupled plasma mass spectrometry imaging (LA-ICP-MSI) data: a short overview
por: Weiskirchen, Ralf, et al.
Publicado: (2019)

Commentary: Montelukast Prevents Mice Against Acetaminophen-Induced Liver Injury
por: Weiskirchen, Ralf
Publicado: (2019)

Current Status in Testing for Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH)
por: Drescher, Hannah K., et al.
Publicado: (2019)

Cellular and Molecular Mechanisms Underlying Liver Fibrosis Regression
por: Caligiuri, Alessandra, et al.
Publicado: (2021)

Editorial: Liver Myofibroblasts
por: Kanta, Jiri, et al.
Publicado: (2016)

Experimental liver fibrosis research: update on animal models, legal issues and translational aspects
por: Liedtke, Christian, et al.
Publicado: (2013)

Fructose: A Dietary Sugar in Crosstalk with Microbiota Contributing to the Development and Progression of Non-Alcoholic Liver Disease
por: Lambertz, Jessica, et al.
Publicado: (2017)

Overview of CircRNAs Roles and Mechanisms in Liver Fibrosis
por: Wang, Gaiping, et al.
Publicado: (2023)

Relevance of Autophagy in Parenchymal and Non-Parenchymal Liver Cells for Health and Disease
por: Weiskirchen, Ralf, et al.
Publicado: (2019)

Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-β as major players and therapeutic targets
por: Gressner, A M, et al.
Publicado: (2006)

α2-Adrenergic Receptor in Liver Fibrosis: Implications for the Adrenoblocker Mesedin
por: Schwinghammer, Ute A., et al.
Publicado: (2020)

Deficiency in four and one half LIM domain protein 2 (FHL2) aggravates liver fibrosis in mice
por: Huss, Sebastian, et al.
Publicado: (2013)

All You Can Feed: Some Comments on Production of Mouse Diets Used in Biomedical Research with Special Emphasis on Non-Alcoholic Fatty Liver Disease Research
por: Weiskirchen, Sabine, et al.
Publicado: (2020)

An Overview on Conventional and Non-Conventional Therapeutic Approaches for the Treatment of Candidiasis and Underlying Resistance Mechanisms in Clinical Strains
por: Salazar, Sara B., et al.
Publicado: (2020)

Chronic Kidney Disease: Underlying Molecular Mechanisms—A Special Issue Overview
por: Belo, Luís, et al.
Publicado: (2023)

Recent Advances in Practical Methods for Liver Cell Biology: A Short Overview
por: Torres, Sandra, et al.
Publicado: (2020)

Editorial: Macrophages in Liver Disease
por: Bansal, Ruchi, et al.
Publicado: (2020)

Mast Cells in Liver Fibrogenesis
por: Weiskirchen, Ralf, et al.
Publicado: (2019)

Combined pulmonary fibrosis and emphysema: an increasingly recognized condition
por: Dias, Olívia Meira, et al.
Publicado: (2014)

Liver Fibrosis—From Mechanisms of Injury to Modulation of Disease
por: Liedtke, Christian, et al.
Publicado: (2022)

Adenoviral expression of a transforming growth factor-β1 antisense mRNA is effective in preventing liver fibrosis in bile-duct ligated rats
por: Arias, Monica, et al.
Publicado: (2003)

Evolving concepts of liver fibrogenesis provide new diagnostic and therapeutic options
por: Gressner, Olav A, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_tejmfesicafbq94j87l205vj2q